BL
BlossomHill Therapeutics, Inc.
BLSM · NASDAQ
$25.25 -4.25% (-$1.12)
1M +57.52%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 0.00x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BLSM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jing Rong Jean Cui
Employees
63
Headquarters
San Diego